Telo Genomics Launches Physician Experience Program in the United States
SMART Observational Study a Critical Step Toward Full Platform Availability Toronto, Ontario–(Newsfile Corp – Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), (the “Company” or “Telo”), an emerging...